Dataset Information

Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery.

ABSTRACT:

Background

In breast cancer patients receiving radiotherapy (RT), accurate target delineation and reduction of radiation doses to the nearby normal organs is important. However, manual clinical target volume (CTV) and organs-at-risk (OARs) segmentation for treatment planning increases physicians' workload and inter-physician variability considerably. In this study, we evaluated the potential benefits of deep learning-based auto-segmented contours by comparing them to manually delineated contours for breast cancer patients.

Methods

CTVs for bilateral breasts, regional lymph nodes, and OARs (including the heart, lungs, esophagus, spinal cord, and thyroid) were manually delineated on planning computed tomography scans of 111 breast cancer patients who received breast-conserving surgery. Subsequently, a two-stage convolutional neural network algorithm was used. Quantitative metrics, including the Dice similarity coefficient (DSC) and 95% Hausdorff distance, and qualitative scoring by two panels from 10 institutions were used for analysis. Inter-observer variability and delineation time were assessed; furthermore, dose-volume histograms and dosimetric parameters were also analyzed using another set of patient data.

Results

The correlation between the auto-segmented and manual contours was acceptable for OARs, with a mean DSC higher than 0.80 for all OARs. In addition, the CTVs showed favorable results, with mean DSCs higher than 0.70 for all breast and regional lymph node CTVs. Furthermore, qualitative subjective scoring showed that the results were acceptable for all CTVs and OARs, with a median score of at least 8 (possible range: 0-10) for (1) the differences between manual and auto-segmented contours and (2) the extent to which auto-segmentation would assist physicians in clinical practice. The differences in dosimetric parameters between the auto-segmented and manual contours were minimal.

Conclusions

The feasibility of deep learning-based auto-segmentation in breast RT planning was demonstrated. Although deep learning-based auto-segmentation cannot be a substitute for radiation oncologists, it is a useful tool with excellent potential in assisting radiation oncologists in the future. Trial registration Retrospectively registered.

SUBMITTER: Chung SY

PROVIDER: S-EPMC7905884 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery.

Chung Seung Yeun SY Chang Jee Suk JS Choi Min Seo MS Chang Yongjin Y Choi Byong Su BS Chun Jaehee J Keum Ki Chang KC Kim Jin Sung JS Kim Yong Bae YB

Radiation oncology (London, England) 20210225 1

<h4>Background</h4>In breast cancer patients receiving radiotherapy (RT), accurate target delineation and reduction of radiation doses to the nearby normal organs is important. However, manual clinical target volume (CTV) and organs-at-risk (OARs) segmentation for treatment planning increases physicians' workload and inter-physician variability considerably. In this study, we evaluated the potential benefits of deep learning-based auto-segmented contours by comparing them to manually delineated ...[more]

PMID: 33632248

Similar Datasets

Project description:Purpose Fast and accurate auto-segmentation on daily images is essential for magnetic resonance imaging (MRI)–guided adaptive radiation therapy (ART). However, the state-of-the-art auto-segmentation based on deep learning still has limited success, particularly for complex structures in the abdomen. This study aimed to develop an automatic contour refinement (ACR) process to quickly correct for unacceptable auto-segmented contours. Methods and Materials An improved level set–based active contour model (ACM) was implemented for the ACR process and was tested on the deep learning–based auto-segmentation of 80 abdominal MRI sets along with their ground truth contours. The performance of the ACR process was evaluated using 4 contour accuracy metrics: the Dice similarity coefficient (DSC), mean distance to agreement (MDA), surface DSC, and added path length (APL) on the auto-segmented contours of the small bowel, large bowel, combined bowels, pancreas, duodenum, and stomach. Results A portion (3%-39%) of the corrected contours became practically acceptable per the American Association of Physicists in Medicine Task Group 132 (TG-132) recommendation (DSC >0.8 and MDA <3 mm). The best correction performance was seen in the combined bowels, where for the contours with major errors (initial DSC <0.5 or MDA >8 mm), the mean DSC increased from 0.34 to 0.59, the mean MDA decreased from 7.02 mm to 5.23 mm, and the APL reduced by almost 20 mm, whereas for the contours with minor errors, the mean DSC increased from 0.72 to 0.79, the mean MDA decreased from 3.35 mm to 3.29 mm, and more than one-third (39%) of the ACR contours became clinically acceptable. The execution time for the ACR process on one subregion was less than 2 seconds using an NVIDIA GTX 1060 GPU. Conclusions The ACR process implemented based on the ACM was able to quickly correct for some inaccurate contours produced from MRI-based deep learning auto-segmentation of complex abdominal anatomy. The ACR method may be integrated into the auto-segmentation step to accelerate the process of MRI-guided ART.

Project description:PurposeTo investigate the dosimetric impact of deep learning-based auto-segmentation of organs at risk (OARs) on nasopharyngeal and rectal cancer.Methods and materialsTwenty patients, including ten nasopharyngeal carcinoma (NPC) patients and ten rectal cancer patients, who received radiotherapy in our department were enrolled in this study. Two deep learning-based auto-segmentation systems, including an in-house developed system (FD) and a commercial product (UIH), were used to generate two auto-segmented OARs sets (OAR_FD and OAR_UIH). Treatment plans based on auto-segmented OARs and following our clinical requirements were generated for each patient on each OARs sets (Plan_FD and Plan_UIH). Geometric metrics (Hausdorff distance (HD), mean distance to agreement (MDA), the Dice similarity coefficient (DICE) and the Jaccard index) were calculated for geometric evaluation. The dosimetric impact was evaluated by comparing Plan_FD and Plan_UIH to original clinically approved plans (Plan_Manual) with dose-volume metrics and 3D gamma analysis. Spearman's correlation analysis was performed to investigate the correlation between dosimetric difference and geometric metrics.ResultsFD and UIH could provide similar geometric performance in parotids, temporal lobes, lens, and eyes (DICE, p > 0.05). OAR_FD had better geometric performance in the optic nerves, oral cavity, larynx, and femoral heads (DICE, p < 0.05). OAR_UIH had better geometric performance in the bladder (DICE, p < 0.05). In dosimetric analysis, both Plan_FD and Plan_UIH had nonsignificant dosimetric differences compared to Plan_Manual for most PTV and OARs dose-volume metrics. The only significant dosimetric difference was the max dose of the left temporal lobe for Plan_FD vs. Plan_Manual (p = 0.05). Only one significant correlation was found between the mean dose of the femoral head and its HD index (R = 0.4, p = 0.01), there is no OARs showed strong correlation between its dosimetric difference and all of four geometric metrics.ConclusionsDeep learning-based OARs auto-segmentation for NPC and rectal cancer has a nonsignificant impact on most PTV and OARs dose-volume metrics. Correlations between the auto-segmentation geometric metric and dosimetric difference were not observed for most OARs.

Dataset Information

Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery.

Background

Methods

Results

Conclusions

Publications

Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets